288 related articles for article (PubMed ID: 28304306)
1. The Progression of Alzheimer's Disease: Are Fast Decliners Really Fast? A Four-Year Follow-Up.
Barocco F; Spallazzi M; Concari L; Gardini S; Pelosi A; Caffarra P
J Alzheimers Dis; 2017; 57(3):775-786. PubMed ID: 28304306
[TBL] [Abstract][Full Text] [Related]
2. Fast cognitive decline at the time of dementia diagnosis: a major prognostic factor for survival in the community.
Carcaillon L; Pérès K; Péré JJ; Helmer C; Orgogozo JM; Dartigues JF
Dement Geriatr Cogn Disord; 2007; 23(6):439-45. PubMed ID: 17476100
[TBL] [Abstract][Full Text] [Related]
3. Distinct dynamic profiles of microglial activation are associated with progression of Alzheimer's disease.
Hamelin L; Lagarde J; Dorothée G; Potier MC; Corlier F; Kuhnast B; Caillé F; Dubois B; Fillon L; Chupin M; Bottlaender M; Sarazin M
Brain; 2018 Jun; 141(6):1855-1870. PubMed ID: 29608645
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of rapid decline in mini mental state examination in clinical practice for prognosis in Alzheimer's disease.
Soto ME; Andrieu S; Cantet C; Reynish E; Ousset PJ; Arbus C; Gillette-Guyonnet S; Nourhashémi F; Vellas B;
Dement Geriatr Cogn Disord; 2008; 26(2):109-16. PubMed ID: 18617740
[TBL] [Abstract][Full Text] [Related]
5. Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).
Hanon O; Latour F; Seux ML; Lenoir H; Forette F; Rigaud AS;
J Nutr Health Aging; 2005; 9(2):106-11. PubMed ID: 15791354
[TBL] [Abstract][Full Text] [Related]
6. Smell identification function as a severity and progression marker in Alzheimer's disease.
Velayudhan L; Pritchard M; Powell JF; Proitsi P; Lovestone S
Int Psychogeriatr; 2013 Jul; 25(7):1157-66. PubMed ID: 23597130
[TBL] [Abstract][Full Text] [Related]
7. Predicting disease progression in Alzheimer's disease: the role of neuropsychiatric syndromes on functional and cognitive decline.
Palmer K; Lupo F; Perri R; Salamone G; Fadda L; Caltagirone C; Musicco M; Cravello L
J Alzheimers Dis; 2011; 24(1):35-45. PubMed ID: 21157019
[TBL] [Abstract][Full Text] [Related]
8. A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline.
Suh GH; Ju YS; Yeon BK; Shah A
Int J Geriatr Psychiatry; 2004 Sep; 19(9):817-24. PubMed ID: 15352138
[TBL] [Abstract][Full Text] [Related]
9. Results of a multi-level therapeutic approach for Alzheimer's disease subjects in the "real world" (CRONOS project): a 36-week follow-up study.
Bellelli G; Lucchi E; Minicuci N; Rozzini L; Bianchetti A; Padovani A; Trabucchi M
Aging Clin Exp Res; 2005 Feb; 17(1):54-61. PubMed ID: 15847123
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal changes in functional disability in Alzheimer's disease patients.
Arrighi HM; Gélinas I; McLaughlin TP; Buchanan J; Gauthier S
Int Psychogeriatr; 2013 Jun; 25(6):929-37. PubMed ID: 23406898
[TBL] [Abstract][Full Text] [Related]
11. Is functional decline necessary for a diagnosis of Alzheimer's disease?
Park KW; Pavlik VN; Rountree SD; Darby EJ; Doody RS
Dement Geriatr Cogn Disord; 2007; 24(5):375-9. PubMed ID: 17914262
[TBL] [Abstract][Full Text] [Related]
12. Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.
Hallikainen I; Hänninen T; Fraunberg M; Hongisto K; Välimäki T; Hiltunen A; Karppi P; Sivenius J; Soininen H; Koivisto AM;
Int Psychogeriatr; 2013 Aug; 25(8):1335-44. PubMed ID: 23676340
[TBL] [Abstract][Full Text] [Related]
13. Predictors of rapid cognitive decline in Alzheimer's disease: results from the Australian imaging, biomarkers and lifestyle (AIBL) study of ageing.
Sona A; Zhang P; Ames D; Bush AI; Lautenschlager NT; Martins RN; Masters CL; Rowe CC; Szoeke C; Taddei K; Ellis KA;
Int Psychogeriatr; 2012 Feb; 24(2):197-204. PubMed ID: 21749739
[TBL] [Abstract][Full Text] [Related]
14. A qualitative analysis of the mini mental state examination on Alzheimer's disease patients treated with cholinesterase inhibitors.
Lucchi E; Minicuci N; Magnifico F; Mondini S; Calza A; Avanzi S; Villani D; Bellelli G; Trabucchi M
Arch Gerontol Geriatr Suppl; 2004; (9):253-63. PubMed ID: 15207422
[TBL] [Abstract][Full Text] [Related]
15. Cognitive and Functional Decline in Patients With Mild Alzheimer Dementia With or Without Comorbid Diabetes.
Ascher-Svanum H; Chen YF; Hake A; Kahle-Wrobleski K; Schuster D; Kendall D; Heine RJ
Clin Ther; 2015 Jun; 37(6):1195-205. PubMed ID: 25676448
[TBL] [Abstract][Full Text] [Related]
16. Progression of Alzheimer's Disease: A Longitudinal Study in Norwegian Memory Clinics.
Eldholm RS; Barca ML; Persson K; Knapskog AB; Kersten H; Engedal K; Selbæk G; Brækhus A; Skovlund E; Saltvedt I
J Alzheimers Dis; 2018; 61(3):1221-1232. PubMed ID: 29254085
[TBL] [Abstract][Full Text] [Related]
17. Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease.
Masse I; Bordet R; Deplanque D; Al Khedr A; Richard F; Libersa C; Pasquier F
J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1624-9. PubMed ID: 16291883
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
Wilcock GK; Black SE; Hendrix SB; Zavitz KH; Swabb EA; Laughlin MA;
Lancet Neurol; 2008 Jun; 7(6):483-93. PubMed ID: 18450517
[TBL] [Abstract][Full Text] [Related]
19. An abnormal "one-leg balance" test predicts cognitive decline during Alzheimer's disease.
Rolland Y; Abellan van Kan G; Nourhashemi F; Andrieu S; Cantet C; Guyonnet-Gillette S; Vellas B
J Alzheimers Dis; 2009; 16(3):525-31. PubMed ID: 19276547
[TBL] [Abstract][Full Text] [Related]
20. [Perturbations of activities of daily living in Alzheimer's disease. A study of 172 patients with the using a questionnaire completed by caregivers].
Derouesné C; Thibault S; Lozeron P; Baudouin-Madec V; Piquard A; Lacomblez L
Rev Neurol (Paris); 2002 Jul; 158(6-7):684-700. PubMed ID: 12486898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
